Found: 14
Select item for more details and to access through your institution.
iGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real‐world study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1249, doi. 10.1111/dom.14974
- By:
- Publication type:
- Article
Improved patient‐reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2364, doi. 10.1111/dom.14822
- By:
- Publication type:
- Article
Impact of delaying treatment intensification with a glucagon‐like peptide‐1 receptor agonist in patients with type 2 diabetes uncontrolled on basal insulin: A longitudinal study of a US administrative claims database.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 4, p. 831, doi. 10.1111/dom.13156
- By:
- Publication type:
- Article
Evaluating glycaemic control in patients poorly controlled on oral antidiabetic drugs in real‐world setting: Results from assessing the Appropriate Timing of Type 2 diAbetes INtensification (ATTAIN).
- Published in:
- Endocrinology, Diabetes & Metabolism, 2020, v. 3, n. 1, p. N.PAG, doi. 10.1002/edm2.94
- By:
- Publication type:
- Article
Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: An electronic medical record database analysis.
- Published in:
- Endocrinology, Diabetes & Metabolism, 2019, v. 2, n. 3, p. N.PAG, doi. 10.1002/edm2.61
- By:
- Publication type:
- Article
Initiation of iGlarLixi Versus Basal-Bolus Insulin in Adults With Type 2 Diabetes Advancing From Basal Insulin Therapy: The SoliComplex Real-World Study.
- Published in:
- Diabetes Spectrum, 2023, v. 36, n. 3, p. 253, doi. 10.2337/ds22-0064
- By:
- Publication type:
- Article
Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in People with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the US.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 9, p. 1659, doi. 10.1007/s13300-022-01300-5
- By:
- Publication type:
- Article
Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in Patients with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the UK.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 6, p. 1203, doi. 10.1007/s13300-022-01267-3
- By:
- Publication type:
- Article
Cost-Effectiveness of iGlarLixi Versus iDegLira in Type 2 Diabetes Mellitus Inadequately Controlled by GLP-1 Receptor Agonists and Oral Antihyperglycemic Therapy.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 12, p. 3231, doi. 10.1007/s13300-021-01156-1
- By:
- Publication type:
- Article
Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 12, p. 3217, doi. 10.1007/s13300-021-01159-y
- By:
- Publication type:
- Article
Evaluating Glycemic Control in Patients with Type 2 Diabetes Suboptimally Controlled on Basal Insulin: UK ATTAIN Real-World Study.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 5, p. 1847, doi. 10.1007/s13300-019-0667-6
- By:
- Publication type:
- Article
Lack of Treatment Persistence and Treatment Nonadherence as Barriers to Glycaemic Control in Patients with Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 2, p. 437, doi. 10.1007/s13300-019-0590-x
- By:
- Publication type:
- Article
Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1169, doi. 10.1007/s13300-018-0429-x
- By:
- Publication type:
- Article
747-P: Improved Treatment Perceptions with IGlarLixi vs. Premix Insulin in Type 2 Diabetes (T2D) Uncontrolled on Basal Insulin (BI) + Oral Antihyperglycemic Drugs (OADs): Patient-Reported Outcomes (PROs) of the SoliMix Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-747-P
- By:
- Publication type:
- Article